{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:16:20Z","timestamp":1788218180974,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10072-023-07277-8","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T06:01:29Z","timestamp":1703311289000},"page":"1255-1261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neurofilament light chain as a biomarker in neuromyelitis optica spectrum disorder: a comprehensive review and integrated analysis with glial fibrillary acidic protein"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-386X","authenticated-orcid":false,"given":"Sohyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5260-2817","authenticated-orcid":false,"given":"Jae-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-9206","authenticated-orcid":false,"given":"Jin-Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0891","authenticated-orcid":false,"given":"Minsung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9938-5355","authenticated-orcid":false,"given":"Hung Youl","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"issue":"4","key":"7277_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/13524585211024978","volume":"28","author":"H Kim","year":"2022","unstructured":"Kim H, Lee EJ, Kim S, Choi LK, Kim HJ, Kim HW et al (2022) Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder. Mult Scler 28(4):512\u2013521. https:\/\/doi.org\/10.1177\/13524585211024978","journal-title":"Mult Scler"},{"issue":"3","key":"7277_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, Yue JK, D\u2019Anna L, Huss A et al (2022) Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol 18(3):158\u2013172. https:\/\/doi.org\/10.1038\/s41582-021-00616-3","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"7277_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14(10):577\u2013589. https:\/\/doi.org\/10.1038\/s41582-018-0058-z","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"7277_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2022-330412","volume":"94","author":"O Aktas","year":"2023","unstructured":"Aktas O, Hartung HP, Smith MA, Rees WA, Fujihara K, Paul F et al (2023) Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry 94(9):757\u2013768. https:\/\/doi.org\/10.1136\/jnnp-2022-330412","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"7277_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12974-021-02138-7","volume":"18","author":"P Schindler","year":"2021","unstructured":"Schindler P, Grittner U, Oechtering J, Leppert D, Siebert N, Duchow AS et al (2021) Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. J Neuroinflammation 18(1):105. https:\/\/doi.org\/10.1186\/s12974-021-02138-7","journal-title":"J Neuroinflammation"},{"key":"7277_CR6","doi-asserted-by":"publisher","first-page":"647618","DOI":"10.3389\/fimmu.2021.647618","volume":"12","author":"X Chang","year":"2021","unstructured":"Chang X, Huang W, Wang L, ZhangBao J, Zhou L, Lu C et al (2021) Serum neurofilament light and GFAP are associated with disease severity in inflammatory disorders with Aquaporin-4 or myelin oligodendrocyte glycoprotein antibodies. Front Immunol 12:647618. https:\/\/doi.org\/10.3389\/fimmu.2021.647618","journal-title":"Front Immunol"},{"issue":"5","key":"7277_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/jnc.15478","volume":"159","author":"C Liu","year":"2021","unstructured":"Liu C, Lu Y, Wang J, Chang Y, Wang Y, Chen C et al (2021) Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: a cohort study. J Neurochem 159(5):913\u2013922. https:\/\/doi.org\/10.1111\/jnc.15478","journal-title":"J Neurochem"},{"key":"7277_CR8","doi-asserted-by":"publisher","first-page":"175628642110549","DOI":"10.1177\/17562864211054952","volume":"14","author":"TX Zhang","year":"2021","unstructured":"Zhang TX, Chen JS, Du C, Zeng P, Zhang H, Wang X et al (2021) Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder. Ther Adv Neurol Disord 14:17562864211054952. https:\/\/doi.org\/10.1177\/17562864211054952","journal-title":"Ther Adv Neurol Disord"},{"key":"7277_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jocn.2020.11.016","volume":"83","author":"C Liu","year":"2021","unstructured":"Liu C, Zhao L, Fan P, Ko H, Au C, Ng A et al (2021) High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders. J Clin Neurosci 83:108\u2013111. https:\/\/doi.org\/10.1016\/j.jocn.2020.11.016","journal-title":"J Clin Neurosci"},{"key":"7277_CR10","doi-asserted-by":"publisher","first-page":"720907","DOI":"10.3389\/fimmu.2021.720907","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Cui C, Lu Y, Chang Y, Wang Y, Li R et al (2021) Therapeutic response and possible biomarkers in acute attacks of neuromyelitis optica spectrum disorders: a prospective observational study. Front Immunol 12:720907. https:\/\/doi.org\/10.3389\/fimmu.2021.720907","journal-title":"Front Immunol"},{"key":"7277_CR11","doi-asserted-by":"publisher","unstructured":"Hyun JW, Kim Y, Kim SY, Lee MY, Kim SH, Kim HJ.(2021) Investigating the presence of interattack astrocyte damage in neuromyelitis optica spectrum disorder: longitudinal analysis of serum glial fibrillary acidic protein. Neurol Neuroimmunol Neuroinflamm.8(3). doi: https:\/\/doi.org\/10.1212\/NXI.0000000000000965.","DOI":"10.1212\/NXI.0000000000000965"},{"issue":"13","key":"7277_CR12","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","volume":"93","author":"M Watanabe","year":"2019","unstructured":"Watanabe M, Nakamura Y, Michalak Z, Isobe N, Barro C, Leppert D et al (2019) Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology 93(13):e1299\u2013e1311. https:\/\/doi.org\/10.1212\/WNL.0000000000008160","journal-title":"Neurology"},{"key":"7277_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.msard.2019.02.009","volume":"30","author":"L Peng","year":"2019","unstructured":"Peng L, Bi C, Xia D, Mao L, Qian H (2019) Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease. Mult Scler Relat Disord 30:123\u2013128. https:\/\/doi.org\/10.1016\/j.msard.2019.02.009","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"7277_CR14","doi-asserted-by":"publisher","first-page":"205521731774309","DOI":"10.1177\/2055217317743098","volume":"3","author":"S Mariotto","year":"2017","unstructured":"Mariotto S, Farinazzo A, Monaco S, Gajofatto A, Zanusso G, Schanda K et al (2017) Serum neurofilament light chain in NMOSD and related disorders: comparison according to Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies status. Mult Scler J Exp Trans Clin 3(4):2055217317743098. https:\/\/doi.org\/10.1177\/2055217317743098","journal-title":"Mult Scler J Exp Trans Clin"},{"issue":"8","key":"7277_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.neuint.2013.10.008","volume":"63","author":"H Wang","year":"2013","unstructured":"Wang H, Wang C, Qiu W, Lu Z, Hu X, Wang K (2013) Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica. Neurochem Int 63(8):805\u2013808. https:\/\/doi.org\/10.1016\/j.neuint.2013.10.008","journal-title":"Neurochem Int"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07277-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T02:07:07Z","timestamp":1707530827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07277-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,23]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["7277"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07277-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,23]]},"assertion":[{"value":"24 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}